Schostak, Martin A Phase 4 Study of Everolimus to Evaluate Efficacy and Safety in Patients with Metastatic Renal-Cell Carcinoma after Failure of First-Line Sunitinib or Pazopanib (SUNPAZ). [electronic resource] - Urologia internationalis 2020 - 263-268 p. digital Publication Type: Clinical Trial, Phase IV; Journal Article ISSN: 1423-0399 Standard No.: 10.1159/000503870 doi Subjects--Topical Terms: AgedAntineoplastic Agents--adverse effectsCarcinoma, Renal Cell--drug therapyEverolimus--adverse effectsFemaleHumansIndazolesKidney Neoplasms--drug therapyMaleMiddle AgedProspective StudiesPyrimidines--therapeutic useSulfonamides--therapeutic useSunitinib--therapeutic useTreatment FailureTreatment Outcome